SPECIAL SECTION
Imipramine Treatment of Children with Separation Anxiety Disorder

https://doi.org/10.1097/00004583-199201000-00005Get rights and content

Abstract

The efficacy of imipramine was investigated in 20 children (ages 6 to 15) with separation anxiety disorder. Children were treated for a month with vigorous behavioral treatment. If they did not respond, they entered a double-blind, randomized, 6-week trial of imipramine or placebo. Of 45 children accepted, 21 (47%) entered the trial. About half the children improved with either treatment, and no superiority for imipramine was obtained. There was no instance of clinically significant EKG changes. This small study failed to replicate previous findings of imipramine efficacy in a similar, but larger, clinical population. J. Am. Acad. Child Adolesc. Psychiatry, 1992, 31, 1:21–28.

References (29)

  • A.J. Costello et al.

    Diagnostic Interview Schedule for Children

    (1983)
  • G.R. Elliott et al.

    Tricyclic antidepressants: the QT interval and other cardiovascular parameters

    Journal of Child and Adolescent Psychopharmacology

    (1991)
  • R. Gittelman

    Teacher rating scale (modified Conners): anxiety and mood items added

    Psychopharmacol. Bull.

    (1985)
  • R. Gittelman

    Parent's questionnaire (modified Conners): anxiety and mood items added

    Psychopharmacol. Bull.

    (1985)
  • Cited by (0)

    The study was supported, in part, by grants MH-37001 and MH-16434, and MHCRC grant MH-30906.

    View full text